SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-203033
Filing Date
2023-08-04
Accepted
2023-08-03 17:48:29
Documents
12
Period of Report
2023-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d525761d8k.htm   iXBRL 8-K 25338
  Complete submission text file 0001193125-23-203033.txt   143547

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amgn-20230801.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20230801_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20230801_pre.xml EX-101.PRE 10807
6 EXTRACTED XBRL INSTANCE DOCUMENT d525761d8k_htm.xml XML 3267
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 231141451
SIC: 2836 Biological Products, (No Diagnostic Substances)